Increasing of intrathecal CSF excitatory amino acids concentration following morphine challenge in morphine-tolerant rats

Brain Research

Volumn 995, Issue 2, 2004, Pages 253-259

  Wen, Zhi Hong ^a   Chang, Yi Chen ^a   Cherng, Chen Hwan ^a   Wang, Jhi Joung ^b   Tao, Pao Luh ^c   Wong, Chih Shung ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Excitatory amino acids; Microdialysis; Morphine tolerance; NMDA receptor

Indexed keywords

AMINO ACID; ASPARTIC ACID; DIZOCILPINE; EXCITATORY AMINO ACID RECEPTOR; GLUTAMIC ACID; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; SODIUM CHLORIDE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATHETER; CEREBROSPINAL FLUID; CONTROLLED STUDY; DIALYSATE; DOSE RESPONSE; DRUG EFFECT; DRUG RELEASE; DRUG TOLERANCE; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; STATISTICAL SIGNIFICANCE; TAIL FLICK TEST;

EID: 0348112446     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2003.10.008     Document Type: Article

References (46)

1. Aanonsen L.M., Lei G.L., Wilcox G.L. Excitatory amino acid receptors and nociceptive neurotransmission in rat spinal cord. Pain. 41:1991;309-321.
2. Akaola H., Aston-Jones G. Opiate withdrawal-induced hyperactivity of locus coeruleus neurons is substantially mediated by augmented excitatory amino acid input. J. Neurosci. 11:1991;3830-3839.
3. Cahusac P.M.B., Evans R.H., Hill R.G., Rodriquez R.E., Smith D.A.S. The behavioral effects of an N-methyl aspartate receptor antagonist following application to the lumbar spinal cord of conscious rats. Neuropharmacology. 23:1984;719-724.
4. Chen L., Huang L.Y.M. Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by μ-opioids. Neuron. 7:1991;319-326.
5. 2+ block of NMDA-receptor channels as mechanism of modulation. Nature. 356:1991;521-523.
6. Collingridge G.L., Singer W. Excitatory amino acids and synaptic plasticity. Trends Pharmacol. Sci. 11:1990;290-296.
7. Conradt M., Stoffel W. Inhibition of the high-affinity brain glutamate transporter GLAST-1 via direct phosphorylation. J. Neurochem. 68:1997;1244-1251.
8. Crain S.M., Shen K.F. Modulation of opioids analgesia, tolerance and dependence by Gs-coupled, GM1 ganglioside-regulated opioids receptor function. Trends Pharmacol. Sci. 19:1998;358-365.
9. Crain S.M., Shen K.F. Antagonists of excitatory opioids receptor functions enhance morphine's analgesic potency and attenuate opioids tolerance/dependence liability. Pain. 84:2000;121-131.
10. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 65:2001;1-105.
11. Dougherty P.M., Sluka K.A., Sorkin L.S., Westlun K.N., Willis W.D. The role of NMDA and non-NMDA excitatory amino acid receptors in the excitation of primate spinothalamic tract neurons by mechanical, chemical, thermal, and electrical stimuli. J. Neurosci. 12:1992;3025-3041.
12. Granados-Soto V., Kalcheva I., Hua X., Newton A., Yaksh T.L. Spinal PKC activity and expression: role in tolerance produced by continuous spinal morphine infusion. Pain. 85:2000;395-404.
13. 3H]glutamate-binding sites in rat central nervous system. J. Neurosci. 4:1984;2133-2144.
14. Gutstein H.B., Trujillo K.A. MK-801 inhibits the development of morphine tolerance at spinal sites. Brain Res. 626:1993;332-334.
15. Headley P.M., Grillner S. Excitatory amino acids and synaptic transmission: the evidence for a physiological function. Trends Pharmacol. Sci. 11:1990;205-211.
16. Hong M., Milne B., Jhamandas K. Evidence for the involvement of excitatory amino acid pathways in the development of precipitated withdrawal from acute and chronic morphine: an in vivo voltametric study in the rat locus coeruleus. Brain Res. 623:1993;131-141.
17. Hsu M.M., Wong C.S. The role of pain facilitatory systems in opioid tolerance. Acta Anaesthesiol. Sinics. 38:2000;155-166.
18. Huang N.K., Tseng C.J., Wong C.S., Yin T.H., Tung C.S. Effects of acute and chronic morphine on DOPAC and glutamate at subcortical DA terminals in awake rats. Pharmacol. Biochem. Behav. 56:1997;363-371.
19. Jhamandas K.H., Marsala M., Ibuki T., Yaksh T.L. Spinal amino acid release and precipitated withdrawal in rats chronically infused with spinal morphine. J. Neurosci. 16:1996;2758-2766.
20. Kangrga I., Randic M. Outflow of endogenous aspartate and glutamate from the rat spinal dorsal horn in vitro by activation of low- and high-threshold primary afferent fibers: modulation by μ-opioids. Brain Res. 553:1991;347-352.
21. Kest B., Mogil J.S., Shamgar B.E., Kao B., Liebesking J.C., Marek P. The NMDA receptor antagonist MK-801 protects against the development of morphine tolerance after intrathecal administration. Proc. West. Pharmacol. Soc. 36:1996;307-310.
22. Koob G.F., Bloom F.E. Cellular and molecular mechanisms of drug dependence. Science. 242:1988;715-722.
23. Koyuncuoglu H., Nurten A., Yamanturk P., Nurten R. The importance of the number of NMDA receptors in the development of supersensitivity or tolerance to and dependence on morphine. Pharmacol. Res. 39:1999;311-319.
24. Larcher A., Laulin J.P., Celerier E., Le Moal M., Simonnet G. Acute tolerance associated with a single opiate administration: involvement of N-methyl-D-aspartate-dependent pain facilitatory systems. Neuroscience. 84:1998;583-589.
25. Laulin J.P., Celerier E., Larcher A., Le Moal M., Simonnet G. Opiate tolerance to daily heroin administration: an apparent phenomenon associated with enhanced pain sensitivity. Neuroscience. 89:1999;631-636.
26. Maeda T., Kishioka S., Fan X., Fukazawa Y., Shimizu N., Ozaki M., Yamamoto H. Effects of diltiazem and MK-801 on morphine analgesia and pharmacokinetics in mice. Neurosci. Lett. 326:2002;216-218.
27. Mao J., Price D.D., Mayer D.J. Thermal hyperalgesia in association with the development of morphine tolerance in rats: role of excitatory amino acid receptors and protein kinase C. J. Neurosci. 14:1994;2301-2312.
28. Mao J., Price D.D., Mayer D.J. Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain. 62:1995;259-274.
29. Mao J., Sung B., Ji Ru-R., Lim G. Chronic morphine induces downregulation of spinal glutamate transporters: implication in morphine tolerance and abnormal pain sensitivity. J. Neurosci. 22:2002;8312-8323.
30. Marsala M., Malmberg A.B., Yaksh T.L. The spinal loop dialysis catheter: characterization of use in the unanesthetized rat. J. Neurosci. Methods. 62:1995;43-53.
31. Merighi A., Polak J.M., Theodosis D.T. Ultrastructural visualization of glutamate and aspartate immunoreactivity in the rat dorsal horn, with special reference to co-localization of glutamate, substance P and calcitonin-gene related peptide. Neuroscience. 40:1991;67-80.
32. 3H]glutamate-binding sites in rat brain. J. Neurosci. 5:1985;2909-2919.
33. Ozawa T., Nakagawa T., Shige K., Minami M., Satoh M. Changes in the expression of glial glutamate transporters in the rat brain accompanied with morphine dependence and naloxone-precipitated withdrawal. Brain Res. 905:2001;254-258.
34. Raigorodsky G., Urca G. Involvement of N-methyl-D-aspartate receptors in nociception and motor control in the spinal cord of the mouse: behavioral, pharmacological and electrophysiological evidence. Neuroscience. 36:1990;601-610.
35. Sanchez-Prieto J., Budd D.C., Herrero I., Vazquez E., Nicholls D.G. Presynaptic receptors and the control of glutamate exocytosis. Trends Neurosci. 19:1996;235-239.
36. Summers R.W., Wu X.-R., Fitzgerald S.C., Brenneman D.E., Agoston D.V. Excitatory amino acid regulation of the enkephalin phenotype in mouse embryonic spinal cord cultures. Dev. Brain Res. 73:1993;185-192.
37. Tracey D.J., Debiasi S., Phend K., Rustioni A. Aspartate-like immunoreactivity in primary afferent neurons. Neuroscience. 40:1991;673-686.
38. Trotti D., Peng J.B., Dunlop J., Hediger M.A. Inhibition of the glutamate transporter EAAC1 expressed in Xenopus oocytes by phorbol esters. Brain Res. 914:2001;196-203.
39. Trujillo K.A., Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science. 251:1991;85-87.
40. Wen Z.H., Yang L.C., Wang J.J., Chang Y.C., Hsing C.H., Chen J.Y., Wong C.S. Intrathecal pertussis toxin induces thermal hyperalgesia: involvement of excitatory and inhibitory amino acids. Neuroscience. 116:2003;871-878.
41. Wong C.S., Su Y.F., Chang K.J., Watkins W.D. Continuous intrathecal opioid treatment abolishes the regulatory effects of magnesium and guanine nucleotides on mu opioid receptor binding in rat spinal membranes. J. Pharmacol. Exp. Ther. 262:1992;317-326.
42. Wong C.S., Su Y.F., Watkins D.W., Chang K.J. Opioid agonist binding affinity is increased by magnesium in the presence of guanosine diphosphate but decreased by magnesium in the presence of guanyl-5′-yl imidodiphosphate. J. Pharmacol. Exp. Ther. 268:1994;653-661.
43. Wong C.S., Cherng C.H., Luk H.N., Ho S.T., Tung C.S. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at μ-opioid receptors. Eur. J. Pharmacol. 297:1996;27-33.
44. 3H]glutamate binding and inducible nitric oxide synthase expression in the rat spinal cord. Br. J. Anaesth. 85:2000;587-591.
45. Wong C.S., Chang Y.C., Yeh C.C., Huang G.S., Cherng C.H. Loss of intrathecal morphine analgesia in terminal cancer patients is associated with high levels of excitatory amino acids in the CSF. Can. J. Anaesth. 49:2002;561-565.
46. Woolf C.J., Thompson S.W. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation: implication of the treatment of post-injury pain hypersensitivity states. Pain. 44:1991;293-299.